DELENEX THERAPEUTICS AG has a total of 42 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ESBATECH ALCON BIOMED RES UNIT, KALOBIOS PHARMACEUTICALS INC and MICROMET AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | China | 4 | |
#5 | United States | 4 | |
#6 | Hong Kong | 3 | |
#7 | New Zealand | 3 | |
#8 | Brazil | 2 | |
#9 | Canada | 2 | |
#10 | Israel | 2 | |
#11 | Japan | 2 | |
#12 | Republic of Korea | 2 | |
#13 | Mexico | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Enzymes | |
#7 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Kretzschmar Titus | 15 |
#2 | Shamshiev Abdijapar | 14 |
#3 | Auf Der Maur Adrian | 14 |
#4 | Grabulovski Stefanie | 14 |
#5 | Lichtlen Peter | 14 |
#6 | Schmitt Simone | 13 |
#7 | Barberis Alcide | 7 |
#8 | Ewert Stefan | 7 |
#9 | Urech David | 7 |
#10 | Cattepoel Susann | 6 |
Publication | Filing date | Title |
---|---|---|
WO2015086830A1 | Skin penetrating polypeptides | |
EP2931750A1 | Antibodies against il-1 beta | |
MX2015005384A | Binding members to il-1 beta. | |
AU2012244351A1 | Antibodies binding to the extracellular domain of the Receptor Tyrosine Kinase ALK | |
CA2712965A1 | Antigen-binding polypeptides against cartilage degeneration | |
NZ609597A | Scfv antibodies which pass epithelial and/or endothelial layers |